Febutric Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat works by selectively inhibiting xanthine oxidase, an enzyme responsible for converting purines into uric acid, thereby reducing serum uric acid levels. This reduction helps prevent gout attacks, tophi formation, and kidney complications associated with elevated uric acid. Febutric is typically prescribed for long-term management and is especially beneficial for patients who are intolerant to or inadequately controlled by other urate-lowering therapies such as allopurinol. The tablet should be taken orally, usually once daily, with or without food, as directed by a healthcare professional. Patients are advised to maintain adequate hydration to help prevent kidney stones and to avoid alcohol and purine-rich foods to enhance treatment efficacy. Common side effects may include nausea, joint pain, rash, and liver enzyme abnormalities; therefore, regular monitoring of liver function tests and kidney function is recommended during therapy. Febutric is contraindicated in patients with severe liver impairment and those with hypersensitivity to Febuxostat. Always consult a healthcare provider before starting or discontinuing treatment to ensure safe and effective use.